top of page
  • habcfoundationuk

New Biotech, Synaptix, launched to develop treatment for Tubb4a H-abc!

Very exciting news for the H-abc community. Biotech Synaptix has launched and are working hard to develop ASO gene therapy for H-abc and Tubb4a. Click on their website below to learn more.

43 views0 comments


bottom of page